Evidence map›Paper›PMID 28189159›Full record

ReviewThe Nursing clinics of North America2017

Clinical Trials and the Role of the Oncology Clinical Trials Nurse.

Elizabeth A Ness, Cheryl Royce

Abstract readReview
In one paragraph

Review in The Nursing clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Expert consensus on clinical research nurse management in China.Asia-Pacific journal of oncology nursing · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2021
    Article
  15. Oncology clinical trials nursing: A scoping review.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2021
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elizabeth A NessOffice of Education and Compliance, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Room 3-2571, MSC 1206, Bethesda, MD 20892, USA. Electronic address: nesse@mail.nih.gov.
Cheryl RoyceOffice of Research Nursing, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Room 3-2571, MSC 1206, Bethesda, MD 20892, USA.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

Clinical trials are paramount to improving human health. New trial designs and informed consent issues are emerging as a result of genomic profiling and the development of molecularly targeted agents. Many groups and individuals are responsible for ensuring the protection of research participants and the quality of the data produced. The specialty role of the clinical trials nurse (CTN) is critical to clinical trials. Oncology CTNs have competencies that can help guide their practice; however, not all oncology clinical trials are supervised by a nurse. Using the process of engagement, one organization has restructured oncology CTNs under a nurse-supervised model.

Indexed as

Clinical CompetenceClinical Trials as TopicNurse's RoleResearch DesignBiomedical ResearchHumansOncology NursingClinical trialsClinical trials nurseOncology trial designResearch nurse competenciesResearch nursing office

Identifiers

PMID28189159
PMCPMC5321629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.